© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 12, 2013
Over 10 years, lifestyle intervention and metformin were cost-effective or cost saving compared with placebo.
Emily Strouphauer, BSA: Linking Pediatric Psoriasis to Anxiety, Depression
Raj Chovatiya, MD, PhD: Psoriasis Treatment Developments, FDA Approvals in 2022
Lawrence Eichenfield, MD: Phase 3 Trial Data on Ruxolitinib for Atopic Dermatitis